Procept Biorobotics
PRCT
58 hedge funds and large institutions have $1.08B invested in Procept Biorobotics in 2022 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 18 increasing their positions, 16 reducing their positions, and 20 closing their positions.
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
48% more capital invested
Capital invested by funds: $732M → $1.08B (+$351M)
13% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 16
2.71% more ownership
Funds ownership: 67.7% → 70.42% (+2.7%)
5% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 20
3% less funds holding
Funds holding: 60 → 58 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$58.8M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$26M |
| 3 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$6.94M |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$4.33M |
| 5 |
DI
DUMAC Inc
Durham,
North Carolina
|
+$3.98M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Viking Global Investors
Stamford,
Connecticut
|
-$30.1M |
| 2 |
DFO
Duquesne Family Office
New York
|
-$12.8M |
| 3 |
CI
CPMG Inc
Dallas,
Texas
|
-$7.32M |
| 4 |
PC
PointState Capital
New York
|
-$6.77M |
| 5 |
Renaissance Technologies
New York
|
-$4.48M |
PRCT Hedge Fund Activity: Q1 2022 in Review
58 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Procept Biorobotics (PRCT) for Q1 2022, worth a combined $1.08B — up 48% from $732M a quarter earlier.
Sellers outnumbered buyers: 20 funds closed out of PRCT and 19 opened new positions — a net loss of 1 holder — while 16 trimmed existing stakes and 18 added.
The largest buyer was T. Rowe Price Associates, adding an estimated $58.8M. The largest seller was Viking Global Investors, cutting an estimated $30.1M.
- 58 institutional investors held Procept Biorobotics (PRCT) as of Q1 2022, down from 60 in Q4 2021.
- Funds reported $1.08B of Procept Biorobotics stock for Q1 2022, up 48% quarter-over-quarter.
- 19 funds opened new Procept Biorobotics positions in Q1 2022 and 20 closed out, a net change of -1 holder.
- The largest Procept Biorobotics buyer in Q1 2022 was T. Rowe Price Associates, an estimated $58.8M added.
- The largest Procept Biorobotics seller in Q1 2022 was Viking Global Investors, an estimated $30.1M sold.
Based on aggregated 13F filings for Q1 2022.